One of the goals of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasia (HAP-CRC-MPN) is to educate physicians, patients and their families about new research findings and available treatments for myeloproliferative neoplasms (MPN).
As part of our mission to educate, we have established collaborations with national patient support groups and regularly publish articles about available therapies in the Foundations’ newsletters. In addition, Dr. Verstovsek is frequently and an invited speaker at national and international scientific meetings, including annual meetings of the American Society of Hematology, American Society for Clinical Oncology, and the European Hematology Association. Dr. Verstovsek is a also a frequent speaker at patient educational meetings and symposia held in various cities across the United States.
For South Texas, Houston contact
For North Texas, Dallas/Fort Worth contact